How do I taper off Lexapro (escitalopram) and start Buspar (buspirone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Taper Off Lexapro and Start Buspar

When transitioning from escitalopram (Lexapro) to buspirone (Buspar), a gradual taper of escitalopram over several weeks is recommended to minimize withdrawal symptoms, followed by initiation of buspirone after escitalopram is reduced to a low dose or discontinued completely. This approach minimizes the risk of SSRI withdrawal syndrome while allowing for effective anxiety management during the transition.

Escitalopram (Lexapro) Tapering Protocol

  • Begin with a slow taper of escitalopram, reducing by approximately 10% of the current dose every 1-2 weeks to minimize withdrawal symptoms 1
  • For patients on higher doses (e.g., 20mg), consider an initial reduction to 15mg for 1-2 weeks, then 10mg for 1-2 weeks, then 5mg for 1-2 weeks, before discontinuing 1, 2
  • For patients already on 10mg, consider reducing to 5mg for 2 weeks before discontinuing 1, 2
  • During the final stages of tapering, consider even smaller dose reductions (e.g., 5mg to 2.5mg) to minimize withdrawal effects 1, 3
  • Extended tapering over months may be necessary for patients who have been on escitalopram for years or who experience significant withdrawal symptoms 3, 4

Managing SSRI Withdrawal Symptoms

  • Monitor for common withdrawal symptoms including dizziness, nausea, headache, irritability, anxiety, insomnia, and sensory disturbances 2
  • If withdrawal symptoms become severe, slow the taper further or temporarily return to the previous dose before attempting a more gradual reduction 2
  • Distinguish between withdrawal symptoms (which typically emerge within days of dose reduction and are time-limited) and recurrence of the original condition 1
  • Consider using adjunctive medications temporarily to manage specific withdrawal symptoms (e.g., antihistamines for sleep disturbances) 2

Initiating Buspirone (Buspar)

  • Begin buspirone after escitalopram has been reduced to a low dose (e.g., 5mg) or completely discontinued 5
  • Start with a low dose of buspirone, typically 5mg twice daily 5
  • Gradually increase buspirone dose by 5mg every 2-3 days as tolerated 5
  • Target buspirone dose is typically 15-30mg daily, divided into 2-3 doses 5
  • Allow 2-4 weeks for buspirone to reach full therapeutic effect; it does not work immediately like benzodiazepines 5

Important Considerations

  • Buspirone has a different mechanism of action than escitalopram, primarily affecting 5-HT1A receptors rather than blocking serotonin reuptake 5
  • Unlike escitalopram, buspirone does not cause physical dependence or withdrawal symptoms 5
  • Buspirone has minimal sedation effects and does not impair psychomotor function 5
  • Buspirone is specifically indicated for generalized anxiety disorder and may not be effective for all conditions treated by escitalopram 5

Monitoring During Transition

  • Schedule follow-up appointments every 1-2 weeks during the transition period to monitor for withdrawal symptoms and therapeutic response 2
  • Assess for return of original symptoms versus emergence of withdrawal symptoms 1
  • If anxiety symptoms worsen significantly during the transition, consider slowing the escitalopram taper or increasing the buspirone dose more quickly 2
  • Document mood, anxiety levels, sleep quality, and side effects at each follow-up 2

Special Considerations

  • For patients with a history of severe anxiety or depression, consider overlapping the medications more extensively (starting buspirone while still on a moderate dose of escitalopram) 2
  • If the patient is also taking benzodiazepines, prioritize tapering those medications only after the escitalopram-to-buspirone transition is complete, as benzodiazepine withdrawal carries greater risks 6
  • Patients with comorbid conditions may require more specialized tapering protocols and closer monitoring 3

References

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Guideline

Benzodiazepine Discontinuation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.